Biotech News

Sequenom, Inc. announced new data from a collaborative project with The Chinese University of Hong Kong, published this week in the Early Edition of the Proceedings of the National Academy of Sciences, that ...

The annual flu shot is recommended for most people, but certain people are at particularly high risk of contracting the nasty bug and its complications.

Quintiles acquires TMD for oncology : From staff reports Dec 2, 2008 DURHAM -- Quintiles Transnational Corp.

Paladin Labs has entered an agreement with GSK and Glaxo Group Ltd. under which Paladin will be the exclusive distributor of Dexedrine in Canada for three years, after which Paladin has the option to purchase ...

Genaera Corporation has announced that dosing of subjects has begun in study MSI-1436C-102 , the multiple ascending dose Phase 1b study of trodusquemine in overweight and obese type 2 diabetics.

Barr Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application for Synthetic Conjugated Estrogens-A 0.625 ...

Nobody said HIV would give up without a fight. As World AIDS Day arrives Dec. 1, scientists are taking a sobering look back at what went wrong in recent, high-profile failures of two human trials of candidate ...

Alkermes Inc. announced today that it has regained full commercialization rights in the United States for the alcoholism treatment Vivitrol.

Spectrum Pharmaceuticals Announces ZEVALIN sBLA Granted Priority Review by the FDA; Target Decision Date of April 2, 2009 2008-12-01 13:27:03 - American Society of Hematology conference - Spectrum ...

Health care products company Johnson & Johnson said Monday it will buy cosmetic-product and breast-implant maker Mentor Corp. for $1.07 billion in a move to boost its presence in cosmetic and reconstructive medicine.

Under the deal, J&J will start a cash tender offer for $31 per share in a move to add breast implants and other products to its Ethicon surgical products unit. The offer is nearly double Mentor's closing price of $16.15 on Friday.

Mentor shares are up $13.85, or 85.8 percent, to $30 in premarket trading.

IMPAX Laboratories, Inc. announced that the U.S. Food and Drug Administration granted final approval of the Company's Abbreviated New Drug Application for a generic version of Wellbutrin XL 150 mg ...

Gov. Janet Napolitano's selection for a job in Washington, D.C., may be secure, but her vision of a research-based economy in Arizona is no sure thing.

DSM Biologics , a business unit of DSM Pharmaceutical Products, and Dutch biotechnology company Crucell N.V. , have signed a commercial license agreement with Hungary-based Gedeon Richter Plc.

Research and Markets has announced the addition of the "Competitor Analysis: Interferon" report to their offering.

AP Photo: Andy Wong A worker uses a machine to cut rice on a test field sewn with different rice varieties in the outskirts of Kunming, capital of southwestern China's Yunnan province, Tuesday, Oct.

The Juvenile Diabetes Research Foundation, the leader in setting the agenda for type 1 diabetes research worldwide and the world's largest charitable funder and advocate of type 1 diabetes research, announced ...

Main Category: Blood / Hematology Also Included In: Pharma Industry / Biotech Industry Pharmacyclics, Inc.

Bedford-based tissue products company Anika Therapeutics Inc. has ended its contract as the U.S. distributor for Artes Medical Inc.

Nov 26, 2008 - EXACT Sciences Corporation announced today it has received notice from the NASDAQ Listing Qualifications Panel that the Company's common stock will be transferred from The NASDAQ Global Market to ...

Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday it will apply again in 2009.